Human Fibrinogen

5 trials 1 recruiting BHaematology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

5 Sponsors

20 Countries

Phase III

Phase II

Phase III: 3 Phase II: 2

Sponsors using this IMP

AstraZeneca AB 1 Azienda Unita Sanitaria Locale Di Bologna 1 Centre Hospitalier Universitaire De Saint Etienne 1 Fondazione Gimema Franco Mandelli Onlus 1 LFB-Biotechnologies 1

All trials

5 total

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLL… Pending

2024-516731-27-00 Phase III 1 country Azienda Unita Sanitaria Locale Di Bologna
A study of fibrinogen concentrate (FGTW) compared to placebo in the management of bleeding in patients undergoing complex cardiac surgery Recruiting

2024-512388-29-00 Phase III 5 countries LFB-Biotechnologies
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
FORMAT Study : Use of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet t… Ended

2024-516494-73-00 Phase II 1 country Centre Hospitalier Universitaire De Saint Etienne
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 Phase III 19 countries Astrazeneca AB

Showing 1–5 of 5 trials

← All drugs A–Z